Lung Cancer Screening Guidelines 2017

Lung cancer screening guidelines 2017 (including nccn lung cancer) - In a paper published in Chest magazine, a group of experts to discuss the latest evidence on the benefits, harms, and the application of small doses of computed chest tomography (CT) in the detection of lung cancer. The study was titled "Screening for Lung cancer: Guide and expert report". The team also presented its conclusions at the 2017 annual meeting in Toronto, Canada (28 October-1 November).

The mortality of lung cancer every year continues to grow and expand beyond colon, san and prostate cancer combined. Currently, based on the results of the pulmonary cancer screening National screening, small CT doses is a standard practice and is considered as an effective screening method for people at high risk. One of the main recommendations of the new guidelines is that the annual screening with small doses CT should be offered asymptomatic smokers and former smokers-aged between 55 and 77 years-that was intensive smoking (30 pack-years or more Much), continues to smoke, or stopped over the last 15 years.

Instead, these guidelines do not recommend small doses of routine CT screening to asymptomatic smokers and former smokers that fall than the previous one, but is considered at high risk, or develop lung cancer. The same recommendation for persons who have less than 30 pack-years of smoking or not included in the 55-77 age range, and for those who quit smoking more than 15 years ago, and did not have a higher risk of having/developing cancer Pulmo According to the calculation of clinical risk prediction.

Persons who have comorbidities (other conditions) who have a negative impact on their ability to maintain assessment findings have been detected on the screen, or tolerate lung cancer treatment, which is detected on the screen early stages, or Substantially limiting life expectancy, is also not recommended for low-dose screening. "These guidelines differ from our previous guidance as we discuss more the dangers and benefits," Peter Mazzone, MD, and president of the guidelines, said in a press release. "We discussed application screening-CT low doses, including who should filter, how to identify the right patients for screening, how they make decision-making visits, how LDCT [small CT doses] and how to manage abnormal results," he added.

Lung cancer screening guidelines - The team says it takes a balance between risk and screening. "The potential benefits of cancer screening is to reduce the number of cancer-related death needs to be balanced with the potential dangers of screening," said Gerard Silvestri, MD, exhibitors and immediate chairman of the thing orientations.

"The current evidence suggests that even in a group with increased risk of cancer, only a fraction of the screens would be beneficial, while everyone was filtered exposed to potential hazards, including physical consequences and psychosocial identification, and then to Assess the nodules that are detected by the display, radiation exposure, overdiagnosis and overtreatment ", he continued. For this reason, our screening recommendation has become more selective and specifically targets populations at increased risk. The current evidence does not support the widespread adoption of the examination of lung cancer outside the patients described in our recommendations," Silvestri concluded.

Computerized dose tomography (CT) low for lung cancer has become a standard practice, largely because of the results of the National long screening. Related evidence continues to evolve, informing the benefits and risks of CT with small doses in clinical practice. Mazzone and ET have presented new evidence regarding the screening of lung cancer with small doses of computerized tomography and to offer new recommendations to the 2017 CHEST.

The summary of the recommendations together with the observations for each recommendation and summaries can be seen at the American College of Medical practitioners, and the full text of which will come to be published in the magazine issue. Lung cancer screening guidelines - Key recommendations and changes to previous guidelines include:

For smokers and ex-asymptomatic smokers aged between 55 - 77 years of age who smoked 30 pack-years or more and either continue to smoke or quit in the last 15 years, it should be offered yearly screening with low dose CT.
For asymptomatic smokers and former smokers who do not meet the smoke and age criteria in the last recommendation, but considered at high risk/develop lung cancer based on clinical risk prediction, low doses of CT screening should not Normally perform.
For people who have accumulated smoking less than 30 pack-years or younger than the age of 55 years or older than the age of 77 or have quit smoking more than 15 years ago, and do not have a high risk of developing lung cancer/on Based on a clinical risk prediction calculation, low-dose screening of CT should not be performed.
For people with comorbidities who affect their ability to tolerate the evaluation of the results detected on the screen, in order to tolerate the treatment of lung cancer is detected at an early stage, or which substantially limits their Life expectancy, a small dose of CT screening should not be done.
"These guidelines differ from our previous orientation because we will go beyond discussing dangers and benefits," said Peter Mazzone, MD, FCCP, president of the guidelines. "We discussed application screening-CT small doses, including which should filter, how to identify suitable patients for screening, how do visit with decision making, how to do a small CT dose, and how to manage abnormal results."

Lung cancer screening guidelines - "The potential benefits of cancer screening is to reduce the number of cancer-related death needs to be balanced with potential dangers of screening," said Gerard Silvestri, MD, FCCP, speaker guide, and chest, the president immediately. "The current evidence suggests that even in the group with a high risk of developing cancer, only a fraction of the screens would be beneficial, while everyone was filtered exposed to potential hazards, including physical and psychosocial consequences of identification and Then evaluate the nodes detected by the screen, radiation exposure, overdiagnosis, and overload. For this reason, our recommendations for screening has expanded to a more selective way and especially the populations of the highest risk. Current evidence does not support large-scale adoption of lung cancer outside the patient described in our recommendations."